Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01196130 · ClinicalTrials.gov registry record
Colorectal Cancer Umbrella Protocol - Assessment of Targeted Therapies Against Colorectal Cancer (ATTACC Program) Screening Protocol
A clinical trial, sponsored by M.D. Anderson Cancer Center.
- Completed
- Registry status
- 1,275
- Enrollment target
NCT01196130: Completed study, sponsored by M.D. Anderson Cancer Center.
NCT01196130 is a clinical trial that has completed, run by M.D. Anderson Cancer Center. The registered enrollment target is 1,275 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01196130 has completed, sponsored by M.D. Anderson Cancer Center.
- COMPLETED
- Registry status
- 1,275 participants
- Enrollment target
Study Summary
The goal of this clinical research study is to test for biomarkers in patients with metastatic or unresectable, locally advanced colorectal cancer. Biomarkers are chemical "markers" in the tumor tissue and/or blood that may be related to your reaction to cancer drugs. This is an investigational study. This study's biomarker testing is for research purposes only. Up to 1280 patients will be enrolled in this study. All will be enrolled at MD Anderson.
Interventions
- BEHAVIORAL Cancer Symptom Questionnaire
- OTHER Biomarker Testing
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,275 participants |
| Start Date | 2010-08 |
| Est. Completion | 2022-12-09 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01196130
The ClinicalTrials.gov registry entry for NCT01196130 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 1,275 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Cancer Symptom Questionnaire is the first listed.
NCT01196130 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01196130 about?
NCT01196130 is a clinical study titled "Colorectal Cancer Umbrella Protocol - Assessment of Targeted Therapies Against Colorectal Cancer (ATTACC Program) Screening Protocol". The goal of this clinical research study is to test for biomarkers in patients with metastatic or unresectable, locally advanced colorectal cancer. Biomarkers are chemical "markers" in the tumor tissue and/or blood that may be related to your reaction to cancer drugs. This is an investigational stu...
What is the current status of trial NCT01196130?
This trial is currently completed. The enrollment target is 1,275 participants. The study started on 2010-08. Estimated completion is 2022-12-09.
What interventions are being tested in trial NCT01196130?
The interventions under investigation include: Cancer Symptom Questionnaire (BEHAVIORAL), Biomarker Testing (OTHER).
Who is sponsoring clinical trial NCT01196130?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.